Parkinson´s Disease Clinical Trial
Official title:
Gait Training Associated With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Randomised Controlled Trial
The aim of this study is to compare two physical therapy training consisting of gait
training that are distinguished by one being associated with tasks that require handling of
the main executive functions, performed by individuals with Parkinson's Disease.
The investigators hypothesis is that the experimental group (EG), which hold gait training
with higher cognitive demands (dual-task condition), will make improvements in the
parameters measured (functionality of gait and cognitive ability) to a greater extent
compared to the control group (CG), which hold gait training without executive tasks
(single-task condition).
Status | Recruiting |
Enrollment | 30 |
Est. completion date | July 2013 |
Est. primary completion date | May 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 50 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of Idiopathic PD performed by a neurologist specialist in movement disorders; - In use of dopaminergic medication; - Disease severity of 1 to 3 according to Hoehn & Yahr scale; - Absence of other neurological disorders or co-morbidities that may affect gait; - Absence of dementia (score above 24 on the Mini Mental State Examination - MMSE); - Vision and hearing adequate or corrected to normal; - Ability to walk independently; - Absence of prolonged off state; - Age 50 to 85 years. Exclusion Criteria: - Biomechanical alterations (other pathologies) that could compromise the completion of training; - Presence of depression, detected by the Geriatric Depression Scale (GDS-15); - Presence of any neurological, auditory or visual deficit that could compromise distracting task performance during gait training; - Any changes in drug treatment for PD. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Brazil | Brazil Parkinson Association | São Paulo |
Lead Sponsor | Collaborator |
---|---|
University of Sao Paulo | Coordination for the Improvement of Higher Education Personnel |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dynamic Gait Index | The scale assesses the ability to adapt the gait during motor tasks with different demands. | 05/2013 (Up to ten months) | No |
Secondary | Montreal Cognitive Assessment | This scale was developed in order to detect mild degrees of cognitive impairment. The instrument assesses different cognitive domains such as attention and concentration, executive functions, memory, language, visuo-constructive skills, calculations, and orientation. | 05/2013 (Up to ten months) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01736891 -
Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations
|
Phase 3 | |
Recruiting |
NCT03866603 -
Rostock International Parkinson's Disease Study (ROPAD)
|
||
Completed |
NCT00902941 -
Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline
|
Phase 4 | |
Completed |
NCT03103919 -
Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management
|
Phase 4 | |
Recruiting |
NCT01650610 -
Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Study Protocol
|
N/A | |
Recruiting |
NCT02578849 -
Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia
|
N/A | |
Completed |
NCT01038310 -
Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease
|
||
Completed |
NCT01003535 -
Quantification of Cerebral Cholinergic Function in Parkinson´s Disease by Means of Nuclear Medicine Methods
|
Phase 1 | |
Terminated |
NCT00562198 -
PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding
|
Phase 2 | |
Completed |
NCT01580787 -
Functional Improvement in Patients With Parkinson's Disease After Training in Real or Virtual Environment
|
N/A | |
Completed |
NCT00964652 -
Treadmill Training With Additional Body Load: Effects on Gait of Subjects With Parkinson´s Disease
|
N/A | |
Completed |
NCT01960985 -
Balance Training in Parkinson's Disease Using Cues
|
Phase 3 | |
Completed |
NCT01391741 -
The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson´s Disease (PD)
|
Phase 3 |